BioCentury
ARTICLE | Financial News

Noven hammered on profit warning

August 3, 2001 7:00 AM UTC

Noven (NOVN) was down $14.34 (43%) to $18.98 on 14 million shares on Friday after lowering its profit forecast for the remainder of the year. The drug delivery company said it has not received certain expected product orders for its estrogen transdermal delivery systems from partner Novartis (NVS; SWX:NOVN). ...